首頁 >> 供求商機
| ||||||
Product Citations
| Set Currency |
Santa Cruz Biotechnology's secondary antibodies are available conjugated to either an enzyme, biotin or fluorophore for use in a variety of antibody-based applications including Western Blot, immunostaining, flow cytometry and ELISA. Secondary antibodies are commonly affinity purified against immobilized whole IgG isotypes, including IgG1, IgG2a, IgG2b, IgG3 and IgG4. Santa Cruz Biotechnology offers a wide selection of secondary antibodies, which are used in conjunction with our Cruz Marker™ molecular weight standards. We also provide specialized secondaries, such as pre-adsorbed secondary antibodies, which are pre-adsorbed with human IgG and mouse IgG for immunoglobulin-rich tissues and cells, F（ab’）2 fragment secondary antibodies that reduce non-specific secondary antibody binding to Fc receptors on the cell surface, and isotype-specific secondary antibodies against IgM, IgA and IgY.
Previous Citations
542 total citations Raftogianni A et al. 2012. Effects of interaction of an early experience of reward through maternal contact or its denial with social stress during adolescence on the serotonergic system and the stress responsiveness of adult female rats. Neuroscience. 209: 84-96. View PubMed Entry Hsu YY et al. 2012. Triptolide increases SMN transcript and protein levels in human SMA fibroblasts and improves survival in SMA-like mice [Epub ahead of print]. Br J Pharmacol. . : . View PubMed Entry De Marco, P. et al. 2012. Insulin-like growth factor-I regulates GPER expression and function in cancer cells. Oncogene. : -. View PubMed Entry Lappano, R. et al. 2012. Two novel GPER agonists induce gene expression changes and growth effects in cancer cells. Curr Cancer Drug Targets. : -. View PubMed Entry Lappano, R. et al. 2012. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells. Breast Cancer Res. 14: -. View PubMed Entry |
|  |
17